Private Equity
Performance improvements from Asia Alternatives, Clarus, GGV
1 min read · 30 November 2014
Venture portfolio’s focus on secondaries and funds of funds appears to pay off
2 min read · 24 November 2014
Secondary funds strategy continues to bring results
1 min read · 16 November 2014
CalSTRS sees gains from OrbiMed, Sofinnova, Shasta, GGV
2 min read · 04 November 2014
CalSTRS sees gains from NEA, but a decline from ARCH
2 min read · 29 October 2014
Money manager sees strong gains with IVP, Aisling, JP Morgan funds
2 min read · 21 October 2014
SFERS sees broad gains in recent vintage funds; adds Battery, OrbiMed
1 min read · 13 October 2014
Performance at IVP XII, Clarus Lifesciences II improves last year
2 min read · 06 October 2014
Union Square, OrbiMed lead venture portfolio; gains with funds of funds, too
2 min read · 30 September 2014
Oregon PERS has more than 40 percent of its mid decade portfolio in funds of funds
2 min read · 23 September 2014